adenosine monophosphate has been researched along with Hematologic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bal, W; Balwierz, W; Bień, E; Chaber, R; Dembowska-Bagińska, B; Gryniewicz-Kwiatkowska, O; Irga-Jaworska, N; Kazanowska, B; Krawczuk-Rybak, M; Kruk, A; Książek, A; Matkowska-Kocjan, A; Matysiak, M; Mizia-Malarz, A; Młynarski, W; Ociepa, T; Peregud-Pogorzelski, J; Pierlejewski, F; Raciborska, A; Sawicka-Żukowska, M; Styczyński, J; Szczepański, T; Szmydki-Baran, A; Ussowicz, M; Wachowiak, J; Węcławek-Tompol, J; Zając-Spychała, O; Zakrzewska, Z; Zaucha-Prażmo, A | 1 |
| Diószegi, Á; Farkas, K; Hevessy, Z; Illés, Á; Magyari, F; Nagy, B; Nagy, G; Páyer, E; Pinczés, LI; Sik, M; Simon, Z; Ujfalusi, S | 1 |
| Jiang, X; Jin, Z; Wang, P; Wu, X; Xiao, Y; Zheng, J | 1 |
| Bednar, P; Herout, V; Hrabovsky, S; Husa, P; Kabut, T; Kral, Z; Lengerova, M; Mayer, J; Pacasova, R; Prochazkova, J; Ruzek, D; Weinbergerova, B; Zdrazilova-Dubska, L | 1 |
1 review(s) available for adenosine monophosphate and Hematologic Neoplasms
| Article | Year |
|---|---|
The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Hematologic Neoplasms; Humans; Immunosuppressive Agents; T-Lymphocytes; Tumor Microenvironment | 2023 |
1 trial(s) available for adenosine monophosphate and Hematologic Neoplasms
| Article | Year |
|---|---|
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Czech Republic; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Immunization, Passive; Male; Middle Aged; Prognosis; Retrospective Studies; SARS-CoV-2 | 2021 |
2 other study(ies) available for adenosine monophosphate and Hematologic Neoplasms
| Article | Year |
|---|---|
COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antiviral Agents; Child; Child, Preschool; COVID-19; COVID-19 Serotherapy; Disease Management; Female; Hematologic Neoplasms; Humans; Immunization, Passive; Infant; Male; Poland; SARS-CoV-2 | 2021 |
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies.
Topics: Adenosine Monophosphate; Alanine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Hematologic Neoplasms; Humans; Immunization, Passive; Lymphopenia; Oxygen; SARS-CoV-2 | 2022 |